Simvastatin Prevents Long-Term Cognitive Deficits in Sepsis Survivor Rats by Reducing Neuroinflammation and Neurodegeneration
Autor: | Carlos Henrique Rocha Catalão, Anderson de Oliveira Souza, Evelin Capellari Cárnio, Maria José Alves da Rocha, Adriano Sebollela, Luciane C. Alberici, Nilton Nascimento Santos-Junior, Luís Henrique Angenendt da Costa |
---|---|
Rok vydání: | 2020 |
Předmět: |
Male
0301 basic medicine Simvastatin Hippocampus Pharmacology ASTRÓCITOS Toxicology Neuroprotection Sepsis 03 medical and health sciences 0302 clinical medicine medicine Animals Cognitive Dysfunction Rats Wistar Prefrontal cortex Neuroinflammation Cognitive deficit Inflammation business.industry General Neuroscience Brain Neurodegenerative Diseases medicine.disease Rats 030104 developmental biology Gliosis Hydroxymethylglutaryl-CoA Reductase Inhibitors medicine.symptom business 030217 neurology & neurosurgery medicine.drug |
Zdroj: | Repositório Institucional da USP (Biblioteca Digital da Produção Intelectual) Universidade de São Paulo (USP) instacron:USP |
ISSN: | 1476-3524 1029-8428 |
DOI: | 10.1007/s12640-020-00222-z |
Popis: | Sepsis-associated encephalopathy causes brain dysfunction that can result in cognitive impairments in sepsis survivor patients. In previous work, we showed that simvastatin attenuated oxidative stress in brain structures related to memory in septic rats. However, there is still a need to evaluate the long-term impact of simvastatin administration on brain neurodegenerative processes and cognitive damage in sepsis survivors. Here, we investigated the possible neuroprotective role of simvastatin in neuroinflammation, and neurodegeneration conditions of brain structures related to memory in rats at 10 days after sepsis survival. Male Wistar rats (250–300 g) were submitted to cecal ligation and puncture (CLP, n = 42) or remained as non-manipulated (naive, n = 30). Both groups were treated (before and after the surgery) by gavage with simvastatin (20 mg/kg) or an equivalent volume of saline and observed for 10 days. Simvastatin-treated rats that survived to sepsis showed a reduction in the levels of nitrate, IL1-β, and IL-6 and an increase in Bcl-2 protein expression in the prefrontal cortex and hippocampus, and synaptophysin only in the hippocampus. Immunofluorescence revealed a reduction of glial activation, neurodegeneration, apoptosis, and amyloid aggregates confirmed by quantification of GFAP, Iba-1, phospho Ser396-tau, total tau, cleaved caspase-3, and thioflavin-S in the prefrontal cortex and hippocampus. In addition, treated animals presented better performance in tasks involving habituation memory, discriminative, and aversive memory. These results suggest that statins exert a neuroprotective role by upregulation of the Bcl-2 and gliosis reduction, which may prevent the cognitive deficit observed in sepsis survivor animals. |
Databáze: | OpenAIRE |
Externí odkaz: | |
Nepřihlášeným uživatelům se plný text nezobrazuje | K zobrazení výsledku je třeba se přihlásit. |